Home

nemoj Zlikovac Ekonomski triple therapy after pci 6 months Mržnja potok Pogodi

Dapt Review
Dapt Review

Antithrombotic therapy after pci in atrial fibrillation 2016
Antithrombotic therapy after pci in atrial fibrillation 2016

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With  Oral Anticoagulation Undergoing Percutaneous Coronary Intervention |  Circulation
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation

Cardiovascular Medicine - Novel directions for the management of dual  antiplatelet therapy in patients with coronary artery disease
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease

2018 Canadian Cardiovascular Society/Canadian Association of Interventional  Cardiology Focused Update of the Guidelines for the
2018 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Focused Update of the Guidelines for the

RE-DUAL PCI™ vs PIONEER AF-PCI™
RE-DUAL PCI™ vs PIONEER AF-PCI™

Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With  Oral Anticoagulation Undergoing Percutaneous Coronary Intervention |  Circulation
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention | Circulation

Cardiovascular Medicine - Novel directions for the management of dual  antiplatelet therapy in patients with coronary artery disease
Cardiovascular Medicine - Novel directions for the management of dual antiplatelet therapy in patients with coronary artery disease

Management of Antithrombotic Therapy in Atrial Fibrillation Patients  Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect

Antithrombotic Treatment After Coronary Intervention: Agreement and  Controversy | ECR Journal
Antithrombotic Treatment After Coronary Intervention: Agreement and Controversy | ECR Journal

Antithrombotic therapy in patients with mechanical valve prosthesis... |  Download Scientific Diagram
Antithrombotic therapy in patients with mechanical valve prosthesis... | Download Scientific Diagram

Antithrombotic therapy after an ACS in atrial fibrillation patients... |  Download Scientific Diagram
Antithrombotic therapy after an ACS in atrial fibrillation patients... | Download Scientific Diagram

Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI  for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and  after... 🧐 and finally (N)OAC alone! #
Fernando de la Guía 🩺 on Twitter: "Atrial fibrillation patients undergoing PCI for NSTE-ACS. Triple therapy (N)OAC + DAPT up to 1 week (in hospital) and after... 🧐 and finally (N)OAC alone! #

2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet  Therapy in Patients With Coronary Artery Disease: A Repor
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Repor

Triple therapy: A review of antithrombotic treatment for patients with  atrial fibrillation undergoing percutaneous coronary intervention -  ScienceDirect
Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention - ScienceDirect

Duration of triple therapy in patients requiring oral
Duration of triple therapy in patients requiring oral

JCM | Free Full-Text | Longitudinal Patterns in Antithrombotic Therapy in  Patients with Atrial Fibrillation after Percutaneous Coronary Intervention  in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based  Study | HTML
JCM | Free Full-Text | Longitudinal Patterns in Antithrombotic Therapy in Patients with Atrial Fibrillation after Percutaneous Coronary Intervention in the Non-Vitamin K Oral Anticoagulant Era: A Nationwide Population-Based Study | HTML

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019

Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary  Results of the AUGUSTUS Trial - American College of Cardiology
Antithrombotic Strategy in Patients With AF and Recent ACS or PCI: Primary Results of the AUGUSTUS Trial - American College of Cardiology

British Cardiovascular Society
British Cardiovascular Society

Dual antiplatelet therapy for secondary prevention of coronary artery  disease | Open Heart
Dual antiplatelet therapy for secondary prevention of coronary artery disease | Open Heart

Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous  coronary intervention with stenting - Journal of Cardiology
Reducing the cost of managing patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting - Journal of Cardiology

JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome:  What is New and Why? Insight From the 2020 European Society of Cardiology  Guidelines | HTML
JCM | Free Full-Text | Diagnosis and Management of Acute Coronary Syndrome: What is New and Why? Insight From the 2020 European Society of Cardiology Guidelines | HTML

6-month versus 12-month or longer dual antiplatelet therapy after  percutaneous coronary intervention in patients with acute coronary syndrome  (SMART-DATE): a randomised, open-label, non-inferiority trial.,The Lancet -  X-MOL
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial.,The Lancet - X-MOL